• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用于治疗阿尔茨海默病的鼻内胰岛素

Intranasal Insulin for Alzheimer's Disease.

作者信息

Hallschmid Manfred

机构信息

Institute of Medical Psychology and Behavioral Neurobiology, University of Tübingen, Otfried-Müller-Str. 25, 72076, Tübingen, Germany.

German Center for Diabetes Research (DZD), Tübingen, Germany.

出版信息

CNS Drugs. 2021 Jan;35(1):21-37. doi: 10.1007/s40263-020-00781-x. Epub 2021 Jan 30.

DOI:10.1007/s40263-020-00781-x
PMID:33515428
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7873098/
Abstract

Brain insulin signaling contributes to memory function and might be a viable target in the prevention and treatment of memory impairments including Alzheimer's disease. This short narrative review explores the potential of central nervous system (CNS) insulin administration via the intranasal pathway to improve memory performance in health and disease, with a focus on the most recent results. Proof-of-concept studies and (pilot) clinical trials in individuals with mild cognitive impairment or Alzheimer's disease indicate that acute and prolonged intranasal insulin administration enhances memory performance, and suggest that brain insulin resistance is a pathophysiological factor in Alzheimer's disease with or without concomitant metabolic dysfunction. Intranasally administered insulin is assumed to trigger improvements in synaptic plasticity and regional glucose uptake as well as alleviations of Alzheimer's disease neuropathology; additional contributions of changes in hypothalamus-pituitary-adrenocortical axis activity and sleep-related mechanisms are discussed. While intranasal insulin delivery has been conclusively demonstrated to be effective and safe, the recent outcomes of large-scale clinical studies underline the need for further investigations, which might also yield new insights into sex differences in the response to intranasal insulin and contribute to the optimization of delivery devices to grasp the full potential of intranasal insulin for Alzheimer's disease.

摘要

大脑胰岛素信号传导有助于记忆功能,可能是预防和治疗包括阿尔茨海默病在内的记忆障碍的一个可行靶点。这篇简短的叙述性综述探讨了通过鼻内途径给予中枢神经系统(CNS)胰岛素以改善健康和疾病状态下记忆表现的潜力,重点关注最新研究结果。针对轻度认知障碍或阿尔茨海默病患者的概念验证研究和(先导)临床试验表明,急性和长期鼻内给予胰岛素可提高记忆表现,并提示脑胰岛素抵抗是阿尔茨海默病的一个病理生理因素,无论是否伴有代谢功能障碍。鼻内给予的胰岛素被认为可引发突触可塑性和局部葡萄糖摄取的改善以及阿尔茨海默病神经病理学的缓解;还讨论了下丘脑 - 垂体 - 肾上腺皮质轴活动变化和睡眠相关机制的额外作用。虽然鼻内胰岛素给药已被确凿证明是有效和安全的,但大规模临床研究的最新结果强调了进一步研究的必要性,这也可能为鼻内胰岛素反应中的性别差异带来新见解,并有助于优化给药装置,以充分发挥鼻内胰岛素治疗阿尔茨海默病的潜力。

相似文献

1
Intranasal Insulin for Alzheimer's Disease.用于治疗阿尔茨海默病的鼻内胰岛素
CNS Drugs. 2021 Jan;35(1):21-37. doi: 10.1007/s40263-020-00781-x. Epub 2021 Jan 30.
2
Safety, Efficacy, and Feasibility of Intranasal Insulin for the Treatment of Mild Cognitive Impairment and Alzheimer Disease Dementia: A Randomized Clinical Trial.经鼻给予胰岛素治疗轻度认知障碍和阿尔茨海默病痴呆的安全性、有效性和可行性:一项随机临床试验。
JAMA Neurol. 2020 Sep 1;77(9):1099-1109. doi: 10.1001/jamaneurol.2020.1840.
3
Intranasal Insulin Reduces White Matter Hyperintensity Progression in Association with Improvements in Cognition and CSF Biomarker Profiles in Mild Cognitive Impairment and Alzheimer's Disease.鼻内胰岛素可减缓轻度认知障碍和阿尔茨海默病患者的脑白质高信号进展,同时改善认知功能和脑脊液生物标志物谱。
J Prev Alzheimers Dis. 2021;8(3):240-248. doi: 10.14283/jpad.2021.14.
4
Long-acting intranasal insulin detemir improves cognition for adults with mild cognitive impairment or early-stage Alzheimer's disease dementia.长效鼻内注射地特胰岛素可改善轻度认知障碍或早期阿尔茨海默病性痴呆成人的认知能力。
J Alzheimers Dis. 2015;44(3):897-906. doi: 10.3233/JAD-141791.
5
Intranasal insulin.鼻内胰岛素。
J Neuroendocrinol. 2021 Apr;33(4):e12934. doi: 10.1111/jne.12934. Epub 2021 Jan 28.
6
Sex and ApoE genotype differences in treatment response to two doses of intranasal insulin in adults with mild cognitive impairment or Alzheimer's disease.性别和载脂蛋白 E 基因型对轻中度认知障碍或阿尔茨海默病成人接受两种剂量鼻内胰岛素治疗反应的影响。
J Alzheimers Dis. 2013;35(4):789-97. doi: 10.3233/JAD-122308.
7
Intranasal insulin therapy for Alzheimer disease and amnestic mild cognitive impairment: a pilot clinical trial.经鼻胰岛素治疗阿尔茨海默病和遗忘型轻度认知障碍:一项试点临床试验。
Arch Neurol. 2012 Jan;69(1):29-38. doi: 10.1001/archneurol.2011.233. Epub 2011 Sep 12.
8
Intranasal insulin as a therapeutic option in the treatment of cognitive impairments.鼻腔内给予胰岛素作为治疗认知障碍的一种治疗选择。
Exp Gerontol. 2011 Feb-Mar;46(2-3):112-5. doi: 10.1016/j.exger.2010.08.026. Epub 2010 Sep 16.
9
Intranasal administration of insulin to the brain impacts cognitive function and peripheral metabolism.经鼻腔给予胰岛素至脑部会影响认知功能和外周代谢。
Diabetes Obes Metab. 2012 Mar;14(3):214-21. doi: 10.1111/j.1463-1326.2011.01490.x. Epub 2011 Nov 16.
10
A Phase II, Single-Center, Randomized, Double-Blind, Placebo-Controlled Study of the Safety and Therapeutic Efficacy of Intranasal Glulisine in Amnestic Mild Cognitive Impairment and Probable Mild Alzheimer's Disease.一项评估鼻内谷赖胰岛素用于遗忘型轻度认知障碍和可能的轻度阿尔茨海默病的安全性和疗效的 II 期、单中心、随机、双盲、安慰剂对照研究。
Drugs Aging. 2021 May;38(5):407-415. doi: 10.1007/s40266-021-00845-7. Epub 2021 Mar 15.

引用本文的文献

1
The Janus face of CaMKII: from memory consolidation to neurotoxic switch in Alzheimer's disease.钙调蛋白激酶II的双面性:从记忆巩固到阿尔茨海默病中的神经毒性转变
Arch Toxicol. 2025 Sep 1. doi: 10.1007/s00204-025-04160-7.
2
Intranasal Administration of KCNN2 Blocking Peptide Improves Deficits in Cognitive Flexibility in Mouse Model of Fetal Alcohol Spectrum Disorders.鼻内给予KCNN2阻断肽可改善胎儿酒精谱系障碍小鼠模型的认知灵活性缺陷。
Int J Neuropsychopharmacol. 2025 Sep 1;28(9). doi: 10.1093/ijnp/pyaf055.
3
Nasal Residence Depending on the Administered Dosage Form: Impact of Formulation Type on the In Vivo Nasal Retention Time of Drugs in Rats.根据给药剂型的鼻腔滞留情况:剂型类型对大鼠体内药物鼻腔滞留时间的影响
Pharmaceutics. 2025 Jun 30;17(7):863. doi: 10.3390/pharmaceutics17070863.
4
Vanadyl sulfate restores memory impairment in streptozotocin-induced rat model of sporadic alzheimer's disease by repressing FoxO1 gene expression.硫酸氧钒通过抑制FoxO1基因表达恢复链脲佐菌素诱导的散发性阿尔茨海默病大鼠模型中的记忆损伤。
Sci Rep. 2025 Jul 26;15(1):27293. doi: 10.1038/s41598-025-12426-4.
5
First-in-human positron emission tomography study of intranasal insulin in aging and MCI.衰老和轻度认知障碍患者鼻内胰岛素的首次人体正电子发射断层扫描研究。
Alzheimers Dement (N Y). 2025 Jul 23;11(3):e70123. doi: 10.1002/trc2.70123. eCollection 2025 Jul-Sep.
6
Increased Brain Glutathione Levels by Intranasal Insulin Administration.经鼻给予胰岛素可提高大脑谷胱甘肽水平。
Curr Issues Mol Biol. 2025 Apr 17;47(4):284. doi: 10.3390/cimb47040284.
7
Pathological mechanisms and treatment progression of Alzheimer's disease.阿尔茨海默病的病理机制与治疗进展
Eur J Med Res. 2025 Jul 14;30(1):625. doi: 10.1186/s40001-025-02886-9.
8
Dorothy Hodgkin lecture 2024: Insulin regulation of mitochondrial biogenesis and function-Impact of dysregulation of mitochondrial function in diabetes and its complications.2024年多萝西·霍奇金讲座:胰岛素对线粒体生物发生和功能的调节——线粒体功能失调在糖尿病及其并发症中的影响
Diabet Med. 2025 Jul 1:e70086. doi: 10.1111/dme.70086.
9
Intranasal Drug Delivery Technology in the Treatment of Central Nervous System Diseases: Challenges, Advances, and Future Research Directions.鼻腔给药技术在中枢神经系统疾病治疗中的应用:挑战、进展与未来研究方向
Pharmaceutics. 2025 Jun 13;17(6):775. doi: 10.3390/pharmaceutics17060775.
10
The Nasal-Brain Drug Delivery Route: Mechanisms and Applications to Central Nervous System Diseases.鼻-脑给药途径:作用机制及其在中枢神经系统疾病中的应用
MedComm (2020). 2025 Jun 6;6(6):e70213. doi: 10.1002/mco2.70213. eCollection 2025 Jun.

本文引用的文献

1
Role of Insulin in Neurotrauma and Neurodegeneration: A Review.胰岛素在神经创伤和神经退行性变中的作用:综述
Front Neurosci. 2020 Sep 23;14:547175. doi: 10.3389/fnins.2020.547175. eCollection 2020.
2
Intranasal Delivery of Targeted Nanoparticles Loaded With miR-132 to Brain for the Treatment of Neurodegenerative Diseases.负载miR-132的靶向纳米颗粒经鼻递送至脑用于治疗神经退行性疾病
Front Pharmacol. 2020 Aug 6;11:1165. doi: 10.3389/fphar.2020.01165. eCollection 2020.
3
Sex and gender: modifiers of health, disease, and medicine.性别与健康、疾病和医学。
Lancet. 2020 Aug 22;396(10250):565-582. doi: 10.1016/S0140-6736(20)31561-0.
4
Advances in the field of intranasal oxytocin research: lessons learned and future directions for clinical research.鼻腔内催产素研究领域的进展:临床研究的经验教训和未来方向。
Mol Psychiatry. 2021 Jan;26(1):80-91. doi: 10.1038/s41380-020-00864-7. Epub 2020 Aug 17.
5
Glucose transporters in brain in health and disease.脑内葡萄糖转运体:在健康与疾病中的作用
Pflugers Arch. 2020 Sep;472(9):1299-1343. doi: 10.1007/s00424-020-02441-x. Epub 2020 Aug 13.
6
Elevating Insulin Signaling Using a Constitutively Active Insulin Receptor Increases Glucose Metabolism and Expression of GLUT3 in Hippocampal Neurons.使用组成型活性胰岛素受体增强胰岛素信号可增加海马神经元中的葡萄糖代谢和GLUT3的表达。
Front Neurosci. 2020 Jul 7;14:668. doi: 10.3389/fnins.2020.00668. eCollection 2020.
7
Brain insulin resistance in Alzheimer's disease and related disorders: mechanisms and therapeutic approaches.阿尔茨海默病及相关疾病中的脑胰岛素抵抗:机制与治疗方法。
Lancet Neurol. 2020 Sep;19(9):758-766. doi: 10.1016/S1474-4422(20)30231-3. Epub 2020 Jul 27.
8
Brain energy rescue: an emerging therapeutic concept for neurodegenerative disorders of ageing.脑能量拯救:衰老相关神经退行性疾病的新兴治疗理念。
Nat Rev Drug Discov. 2020 Sep;19(9):609-633. doi: 10.1038/s41573-020-0072-x. Epub 2020 Jul 24.
9
Association of Peripheral Insulin Resistance and Other Markers of Type 2 Diabetes Mellitus with Brain Amyloid Deposition in Healthy Individuals at Risk of Dementia.健康的痴呆症高危人群中,外周胰岛素抵抗和其他 2 型糖尿病标志物与脑淀粉样蛋白沉积的关系。
J Alzheimers Dis. 2020;76(4):1243-1248. doi: 10.3233/JAD-200145.
10
Safety, Efficacy, and Feasibility of Intranasal Insulin for the Treatment of Mild Cognitive Impairment and Alzheimer Disease Dementia: A Randomized Clinical Trial.经鼻给予胰岛素治疗轻度认知障碍和阿尔茨海默病痴呆的安全性、有效性和可行性:一项随机临床试验。
JAMA Neurol. 2020 Sep 1;77(9):1099-1109. doi: 10.1001/jamaneurol.2020.1840.